 |
 
The Otsuka Group was founded in 1921,in beginning manufacture inorganic compound. Now, the Otsuka Group include Otsuka Pharmaceutical Co., Ltd and other relating corporations consists of more than 153 companies and 36,000 employees in 23 country around the world, Otsuka Group earns total revenues of more than US$10.4 billion annually worldwide. Among these, one third comes from medication field, another one third from food, beverage and nutraceuticals, the rest of it from chemical products and art ceramics.
Founded in 1964, Otsuka Pharmaceutical Co., Ltd. is a healthcare company with the mission statement: “Otsuka - people creating new products for better health worldwide.” Otsuka researches, develops, manufactures and markets innovative products, focusing its core businesses on pharmaceutical products for the treatment of disease and consumer products for the maintenance of everyday health. Otsuka is committed to sustaining high ethical standards and a dynamic corporate culture, working in harmony with local communities and the environment, and thus become a "global enterprise with value creation."
In its pharmaceutical business, Otsuka is committed to the research and development, manufacture, and sale of pharmaceutical products in various therapeutic areas including the central nervous system, circulatory, digestive, respiratory, dermatological, and ophthalmologic fields. With a global network focused in Japan, the United States, and Europe, Otsuka has an accelerated R&D process and promotes the concept of ”personalized medicine” to speed up the development of beneficial new drugs, as well as diagnostic procedures and preventative treatments.
In its consumer products business, Otsuka is engaged in the research and development, manufacture and sale of nutritional products that improve and maintain everyday health. Utilizing the expertise acquired in its pharmaceutical business, Otsuka contributes to people’s health worldwide through the development of products that reflect the health needs of our times.
|